Wave Life Sciences WVE EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Wave Life Sciences’s reported figures.
Based on trailing twelve months.
The official record: Wave Life Sciences’s 10-Q, filed August 8, 2024, on SEC EDGAR. View the filing →
Ask your AI about Wave Life Sciences's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Wave Life Sciences's EBITDA margin?
- Wave Life Sciences (WVE) reported EBITDA margin of -71.8% in Q2 2024.
- How has Wave Life Sciences's EBITDA margin changed year-over-year?
- Wave Life Sciences's EBITDA margin increased by 79.9% year-over-year, from -356.5% to -71.8%.
- What is the long-term trend for Wave Life Sciences's EBITDA margin?
- Over 3 years (2020 to 2023), Wave Life Sciences's EBITDA margin has grown at a -57.5% compound annual growth rate (CAGR), from -723.5% to -55.6%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.